mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease
Abstract Mitochondrial disease associated with the pathogenic m.3243A>G variant is a common, clinically heterogeneous, neurogenetic disorder. Using multiple linear regression and linear mixed modelling, we evaluated which commonly assayed tissue (blood N = 231, urine N = 235, skeletal muscle N = ...
Saved in:
| Main Authors: | John P Grady, Sarah J Pickett, Yi Shiau Ng, Charlotte L Alston, Emma L Blakely, Steven A Hardy, Catherine L Feeney, Alexandra A Bright, Andrew M Schaefer, Gráinne S Gorman, Richard JQ McNally, Robert W Taylor, Doug M Turnbull, Robert McFarland |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2018-05-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201708262 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe clinical manifestation of mitochondrial disease due to the m.3243A>T variant: a case report of early-onset, multi-organ involvement and premature death
by: Hannah Gillespie, et al.
Published: (2025-08-01) -
The quality and detection limits of mitochondrial heteroplasmy by long read nanopore sequencing
by: Barbara Slapnik, et al.
Published: (2024-11-01) -
Tissue-specific responses to TFAM and mtDNA copy number manipulation in prematurely ageing mice
by: Laura Sophie Kremer, et al.
Published: (2025-06-01) -
Tissue-specific mitochondrial DNA, MT-TF, pathogenic variants in mitochondrial myopathies
by: Sylvia Rose, et al.
Published: (2025-06-01) -
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial
by: Amel Karaa, et al.
Published: (2024-11-01)